Q2 2025 Chemours Co Earnings Call Transcript
Key Points
- The Chemours Co (CC) reached a significant settlement with the State of New Jersey, resolving all environmental claims, including PFAS, across four sites, with a net present value of approximately $250 million.
- The company delivered strong second-quarter results, surpassing expectations with improved performance across all three business segments.
- Net sales of Opteon refrigerants grew 65% year over year, contributing to a 35% adjusted EBITDA margin in the TSS segment.
- The ramp-up of Opteon YF capacity expansion at the Corpus Christi site is ahead of schedule, supporting growth during the regulatory transition.
- APM delivered a notable performance with a sequential sales increase of 14%, driven by product sales into the data center cable market and stronger pricing in the SPS Capstone product line.
- The Chemours Co (CC) faced discrete operational issues in TT and APM, including a rail line service interruption and a local power outage at the Washington Works site.
- Operational disruptions in the TT segment are expected to impact third-quarter results, with costs approximating $15 million.
- APM's third-quarter net sales are expected to decrease due to production constraints from the Washington Works downtime, with additional costs approximating $20 million.
- The company anticipates a sequential decrease in third-quarter net sales and adjusted EBITDA across all segments due to seasonality and operational disruptions.
- Despite strong second-quarter performance, the company acknowledges challenges in maintaining operational excellence and reducing business interruptions.
Good morning. My name is Jericho, and I will be your conference operator today. I would like to welcome everyone to The Chemours Company second-quarter 2025 results conference call. (Operator Instructions) I would like to remind everyone that this conference call is being recorded.
I would now like to hand the conference call over to Brandon Ontjes, Vice President, Head of Strategy and Investor Relations for Chemours. You may begin your conference.
Good morning, everybody. Welcome to The Chemours Company's second-quarter 2025 earnings conference call. I'm joined today by Denise Dignam, Chemours' President and Chief Executive Officer; and our Senior Vice President and Chief Financial Officer, Shane Hostetter.
Before we start, I would like to remind you that the comments made on this call, as well as in the supplemental information provided on our website, contain forward-looking statements that involve risks and uncertainties as described in Chemours' SEC filings.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
